Scarica l'app Stockscreener
11.57
4.06%
-0.49
Dopo l'orario di chiusura:
11.61
0.04
+0.35%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché WVE Giù?
Forum
Previsione
Precedente Chiudi:
$12.06
Aprire:
$12.08
Volume 24 ore:
988.71K
Relative Volume:
0.94
Capitalizzazione di mercato:
$1.76B
Reddito:
$113.31M
Utile/perdita netta:
$-57.51M
Rapporto P/E:
-21.04
EPS:
-0.55
Flusso di cassa netto:
$-20.55M
1 W Prestazione:
-3.66%
1M Prestazione:
-6.47%
6M Prestazione:
+75.04%
1 anno Prestazione:
+167.82%
Intervallo 1D:
$11.35
$12.18
Intervallo di 1 settimana:
$11.35
$12.51
Portata 52W:
$3.50
$16.73
Wave Life Sciences Ltd Stock (WVE) Company Profile
Nome
Wave Life Sciences Ltd
Settore
Industria
Telefono
617-949-2900
Indirizzo
7 STRAITS VIEW, SINGAPORE
Confronta WVE con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
WVE
Wave Life Sciences Ltd
|
11.57 | 1.76B | 113.31M | -57.51M | -20.55M | -0.55 |
|
VRTX
Vertex Pharmaceuticals Inc
|
461.68 | 118.90B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
672.98 | 73.95B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
655.13 | 39.81B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
271.31 | 34.99B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
123.77 | 29.67B | 3.30B | -501.07M | 1.03B | -2.1146 |
Wave Life Sciences Ltd Stock (WVE) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-10-16 | Aggiornamento | Raymond James | Outperform → Strong Buy |
| 2024-09-27 | Ripresa | JP Morgan | Overweight |
| 2024-09-19 | Iniziato | B. Riley Securities | Buy |
| 2024-09-09 | Iniziato | JP Morgan | Overweight |
| 2024-05-15 | Iniziato | Wells Fargo | Overweight |
| 2023-12-19 | Aggiornamento | Leerink Partners | Market Perform → Outperform |
| 2023-07-05 | Iniziato | Raymond James | Outperform |
| 2023-05-24 | Downgrade | Jefferies | Buy → Hold |
| 2020-12-15 | Ripresa | H.C. Wainwright | Buy |
| 2020-10-23 | Iniziato | RBC Capital Mkts | Sector Perform |
| 2019-12-31 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| 2019-11-01 | Iniziato | Guggenheim | Buy |
| 2019-07-15 | Iniziato | Cowen | Market Perform |
| 2019-04-17 | Reiterato | H.C. Wainwright | Buy |
| 2018-08-07 | Iniziato | Stifel | Buy |
| 2018-07-23 | Iniziato | H.C. Wainwright | Buy |
| 2018-03-19 | Reiterato | Mizuho | Buy |
| 2017-02-15 | Iniziato | H.C. Wainwright | Buy |
| 2016-11-10 | Ripresa | Leerink Partners | Outperform |
| 2015-12-07 | Iniziato | JMP Securities | Mkt Outperform |
| 2015-12-07 | Iniziato | Jefferies | Buy |
| 2015-12-07 | Iniziato | Leerink Partners | Outperform |
| 2015-12-07 | Iniziato | Sun Trust Rbsn Humphrey | Buy |
Mostra tutto
Wave Life Sciences Ltd Borsa (WVE) Ultime notizie
Moody Aldrich Partners LLC Boosts Stake in Wave Life Sciences Ltd. (NASDAQ:WVE) - MarketBeat
Where are the Opportunities in (WVE) - Stock Traders Daily
Wave Life Sciences (NASDAQ:WVE) delivers shareholders enviable 72% CAGR over 3 years, surging 8.5% in the last week alone - Simply Wall St
(WVE) Trading Advice - Stock Traders Daily
JPMorgan Chase & Co. Sells 16,382 Shares of Wave Life Sciences Ltd. (NASDAQ:WVE) - Defense World
Wave Life Sciences Updates Corporate Presentation in 8-K Filing - Defense World
Wave Wants To Put The Joy Back Into Weight-Loss Drugs - Citeline
Is Wave Life Sciences (WVE) the Top Small Cap Stock to Buy with the Highest Upside Potential? - Yahoo Finance
Wave Life Sciences Highlights Strategic Priorities and Expected 2025 Milestones Ahead of J.P. Morgan Presentation - GlobeNewswire
Wave Life Sciences Advances Obesity Drug WVE-007, Reports Strong DMD Treatment Results - StockTitan
Barclays PLC Has $1.31 Million Stock Position in Wave Life Sciences Ltd. (NASDAQ:WVE) - MarketBeat
Top 10 Small Cap Stocks to Buy with the Highest Upside Potential - Insider Monkey
WAVE Life Sciences (FRA:1U5) Cash From Discontinued Investi - GuruFocus.com
Wave Life Sciences Ltd. (NASDAQ:WVE) Receives $22.22 Average Target Price from Brokerages - MarketBeat
12 Best Growth Stocks Under $25 to Buy Now - Insider Monkey
Is Wave Life Sciences Ltd. (WVE) the Best Growth Stock to Buy Now Under $25? - Yahoo Finance
How to Take Advantage of moves in (WVE) - Stock Traders Daily
Wave Life Sciences Is A Buy On Pipeline Prospects (WVE) - Seeking Alpha
Wave Life Sciences (NASDAQ:WVE) Trading Down 4%Here's What Happened - MarketBeat
Wave Life Sciences (NASDAQ:WVE) Stock Price Up 7.7%What's Next? - MarketBeat
Franklin Resources Inc. Cuts Stock Position in Wave Life Sciences Ltd. (NASDAQ:WVE) - Defense World
Learn to Evaluate (WVE) using the Charts - Stock Traders Daily
Wave Life Sciences Ltd. (NASDAQ:WVE) Shares Purchased by Barclays PLC - MarketBeat
Geode Capital Management LLC Increases Stock Holdings in Wave Life Sciences Ltd. (NASDAQ:WVE) - MarketBeat
Wave Life Sciences (NASDAQ:WVE) Stock Price Down 2.6%Here's Why - MarketBeat
Wave files clinical trial application for WVE-007 - BioWorld Online
State Street Corp Has $19.03 Million Stock Holdings in Wave Life Sciences Ltd. (NASDAQ:WVE) - MarketBeat
Wave Life Sciences Announces Submission of First Clinical Trial Application for WVE-007 (siRNA Targeting INHBE) in Obesity - The Manila Times
Wave Life Sciences Announces Submission of First Clinical - GlobeNewswire
Wave Life Sciences Advances Novel Obesity Drug WVE-007 Targeting INHBE Gene; Clinical Trials Set for 2025 - StockTitan
XTX Topco Ltd Buys Shares of 15,334 Wave Life Sciences Ltd. (NASDAQ:WVE) - Defense World
WAVE Life Sciences (FRA:1U5) Other Long-Term Liabilities : €7.09 Mil (As of Sep. 2024) - GuruFocus.com
WAVE Life Sciences (FRA:1U5) Dividend Payout Ratio : 0.00 (As of Sep. 2024) - GuruFocus.com
Comprehensive Market Analysis of Latest Published 9 Rare Genetic Disorders Reports | DelveInsight - GlobeNewswire Inc.
(WVE) Investment Analysis - Stock Traders Daily
Y Intercept Hong Kong Ltd Has $242,000 Stock Holdings in Wave Life Sciences Ltd. (NASDAQ:WVE) - MarketBeat
Wellington Management Group LLP Reduces Position in Wave Life Sciences Ltd. (NASDAQ:WVE) - MarketBeat
Wave Life Sciences Ltd. (NASDAQ:WVE) Receives Average Recommendation of "Buy" from Brokerages - MarketBeat
Wave Life Sciences to Present at 43rd Annual J.P. Morgan Healthcare Conference - The Manila Times
WaVe Life Sciences' SWOT analysis: RNA editing pioneer's stock faces pivotal year - Investing.com Australia
Point72 Asset Management L.P. Has $230,000 Holdings in Wave Life Sciences Ltd. (NASDAQ:WVE) - MarketBeat
Neurological stocks rise and fall on clinical data; index down - BioWorld Online
Fmr LLC Raises Stock Holdings in Wave Life Sciences Ltd. (NASDAQ:WVE) - MarketBeat
Wave Life Sciences Ltd. (NASDAQ:WVE) Shares Purchased by Charles Schwab Investment Management Inc. - MarketBeat
Can Sai Life Sciences ride the global CRDMO wave? A detailed IPO analysis - Dalal Street Investment Journal
Jacobs Levy Equity Management Inc. Sells 262,075 Shares of Wave Life Sciences Ltd. (NASDAQ:WVE) - MarketBeat
Duchenne Muscular Dystrophy Pipeline Insights 2024: - openPR
RTW Investments LP Makes New Investment in Wave Life Sciences Ltd. (NASDAQ:WVE) - MarketBeat
486,023 Shares in Wave Life Sciences Ltd. (NASDAQ:WVE) Acquired by Polar Asset Management Partners Inc. - MarketBeat
Maven Securities LTD Purchases Shares of 850,000 Wave Life Sciences Ltd. (NASDAQ:WVE) - MarketBeat
Wave Life Sciences Ltd Azioni (WVE) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
3.95%
2.39%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):